![Sanjay Keswani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 246 697 $ am 31.07.2026
Sanjay Keswani is Executive Vice Chairman at ImmunoBrain Checkpoint Ltd. since 2024.
Dr. Keswani is Director at Nura Bio, Inc. Dr. Keswani will be Chief Medical Officer at Neurocrine Biosciences, Inc. starting in 2025.
Formerly, Dr. Keswani was Chief Executive Officer at Rheos Medicines, Inc. from 2018 to 2019.
Dr. Keswani was VP-Exploratory & Clinical Translational Research at Bristol Myers Squibb Co. from 2011 to 2015.
Dr. Keswani was Senior Vice President & Global Head-Neuroscience at F.
Hoffmann-La Roche Ltd. from 2015 to 2018.
Dr. Keswani was Chief Medical Officer & Executive Vice President at Annexon, Inc. from 2019 to 2022.
Dr. Keswani was Member at The Johns Hopkins Hospital, Inc. Dr. Keswani was Assistant Professor at The Johns Hopkins University.
Dr. Keswani graduated from St Bartholomew's Hospital Medical College in 1994.
Dr. Keswani completed undergraduate studies at St Mary's Hospital Medical School in 2002.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.06.2026 | 1’479 ( 0% ) | 246 697 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.06.2025 |
Nura Bio, Inc.
 Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops neuroprotective drugs and therapies | Direktor/Vorstandsmitglied | - |
ImmunoBrain Checkpoint Ltd.
 ImmunoBrain Checkpoint Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company transforming the fight against neurodegeneration and aging by targeting the immune systems | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ANNEXON, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.02.2022 |
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Vorstandsvorsitzender | 01.06.2019 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.09.2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.06.2015 |
The Johns Hopkins Hospital, Inc.
 The Johns Hopkins Hospital, Inc. Hospital/Nursing ManagementHealth Services Operates as a community hospital | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
The Johns Hopkins Hospital, Inc.
The Johns Hopkins Hospital, Inc. Hospital/Nursing ManagementHealth Services Operates as a community hospital | Health Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St Bartholomew's Hospital Medical College
 St Bartholomew's Hospital Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St Mary's Hospital Medical School
 St Mary's Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoBrain Checkpoint Ltd.
ImmunoBrain Checkpoint Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company transforming the fight against neurodegeneration and aging by targeting the immune systems | Health Technology |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Health Technology |
Nura Bio, Inc.
Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops neuroprotective drugs and therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
